Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early...

Dr Edith Perez - Mayo Clinic, Rochester, USA

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

Genomic sequencing helps identify best candidates for adjuvant chemo in...

Dr Ramon Salazar - L'Hospitalet de Llobregat, Barcelona, Spain

Genomic sequencing helps identify best candidates for adjuvant chemo in colorectal cancer ( Dr Ramon Salazar - L'Hospitalet de Llobregat, Barcelona, Spain )

Mantle cell lymphoma: A review of data and expert opinion from ASCO 2014

Prof Franco Cavalli, Prof Gordon McVie

Mantle cell lymphoma: A review of data and expert opinion from ASCO 2014 ( Prof Franco Cavalli, Prof Gordon McVie )

Addition of docetaxel to initial hormone therapy substantially improves...

Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )

First-line bevacizumab plus chemo and cetuximab plus chemo provide similar...

Dr Alan Venook; Prof Gordon McVie

First-line bevacizumab plus chemo and cetuximab plus chemo provide similar survival benefits in metastatic colorectal cancer ( Dr Alan Venook; Prof Gordon McVie )

ASCO 2014: Advances in prostate cancer discussion

Prof Noel Clarke; Dr Cora Sternberg; Dr Kurt Miller, Prof Wysocki

ASCO 2014: Advances in prostate cancer discussion ( Prof Noel Clarke; Dr Cora Sternberg; Dr Kurt Miller, Prof Wysocki )

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early...

Dr Edith Perez - Mayo Clinic, Rochester, USA

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early-stage HER2-positive breast cancer ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

First-line bevacizumab plus chemotherapy and cetuximab plus chemotherapy...

Dr Alan Venook - UCSF, San Francisco, USA

First-line bevacizumab plus chemotherapy and cetuximab plus chemotherapy provide similar survival benefit for patients with metastatic colorectal cancer ( Dr Alan Venook - UCSF, San Francisco, USA )

Addition of docetaxel to initial hormone therapy substantially improves...

Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )

Adjuvant exemestane more effective than tamoxifen when combined with ovarian...

Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona...

Adjuvant exemestane more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer ( Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian...

Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona...

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer ( Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

Comment: Advances in breast cancer presented at ASCO 2014

Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland

Comment: Advances in breast cancer presented at ASCO 2014 ( Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland )

More from ecancer